Transient hypertransaminasemia in paediatric patients with Crohn disease undergoing initial treatment with enteral nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 51, Issue 3, 2010, Pages 336-340

  Schatorjé, Ellen ^a   Hoekstra, Hans ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

child; Crohn disease; enteral nutrition; liver enzymes

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ARTICLE; CHILD; CHILD CARE; CLINICAL ARTICLE; CROHN DISEASE; ENTERIC FEEDING; FEMALE; FOLLOW UP; HUMAN; HYPERTRANSAMINASEMIA; MALE; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD;

ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; CHILD; CROHN DISEASE; ENTERAL NUTRITION; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER DISEASES; MALE; REMISSION INDUCTION;

EID: 77956444705     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181d94f63     Document Type: Article

References (25)

1. van der Zaag-Loonen HJ, Casparie M, Taminiau JA, et al. The incidence of pediatric inflammatory bowel disease in the Netherlands: 1999-2001. J Pediatr Gastroenterol Nutr 2004;38:302-7.
2. Beattie RM, Croft NM, Fell JM, et al. Inflammatory bowel disease. Arch Dis Child 2006;91:426-32.
3. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-58.
4. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev 2007: CD005984.
5. Day AS, Whitten KE, Sidler M, et al. Systematic review: nutritional therapy in pediatric Crohn's disease. Aliment Pharmacol Ther 2008; 27:293-307.
6. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000;31:8-15.
7. Dziechciarz P, Horvath A, Shamir R, et al. Meta-analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007;26:795-806.
8. Taminiau JAJM, de Meer K, Hofman Z. Bepaling van de voedingsbehoeften. In: Werkboek Enterale Voeding bij kinderen; Nederlandse Vereniging voor Kindergeneeskunde (national guideline); VU, 1997:26-47.
9. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
10. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;39:5-41.
11. Lochs H, Dejong C, Hammarqvist F, et al. ESPEN Guidelines on Enteral Nutrition: gastroenterology. Clin Nutr 2006;25: 260-74. (Pubitemid 43811680)
12. Deltenre P, Berson A, Marcelling P, et al. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis. Gut 1999;44:886-8.
13. Braun M, Fraser G, Kunin M, et al. Mesalamine-induced granulomatous hepatitis. Am J Gastroenterol 1999;94:1973-4.
14. Ransford RAJ, Langman MJS. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002; 51:536-9.
15. Dolz C, Xiol X, Abad A, et al. Changes in liver function tests in patients with inflammatory bowel disease on enteral nutrition. J Parenter Enteral Nutr 1989;13:401-5.
16. Godeberge Ph, Cosnes J, Gendre JP, et al. Étude prospective des anomalies des test hépatiques au cours de l'alimentation entérale continue. Ann Gastroentérol Hépatol 1989;25:295-8.
17. Etukudo MH, Agbedana EO, Akinyinka OO, et al. Plasma electrolytes, total cholesterol, liver enzymes, and selected antioxidant status in protein energy malnutrition. Afr J Med Sci 1999;28:81-5.
18. Ozawa Y, Shimizu T, Shishiba Y. Elevation of serum aminotransferase as a sign of multiorgan-disorders in severely emaciated anorexia nervosa. Intern Med 1998;37:32-9.
19. Mehanna HM, Moledine J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ 2008;336:1495-8.
20. Afzal NA, Addai S, Fagbemi S, et al. Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr 2002;21:515-20.
21. Fisher M, Simpser E, Schneider M. Hypophosphatemia secondary to oral refeeding in anorexia nervosa. Int J Eat Disord 2000;28:181-7.
22. Bregenzer N, Hartmann A, Strauch U, et al. Increased insulin resistance and b cell activity in patients with Crohn's disease. Inflamm Bowel Dis 2006;12:53-6.
23. Steiner SJ, Pfefferkorn MD, Fitzgerald JF, et al. Carbohydrate and lipid metabolism following infliximab therapy in pediatric Crohn's disease. Pediatr Res 2008;64:673-6.
24. Koutroubakis IE, Oustamanolakis P, Malliaraki N, et al. Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2009;21:283-8.
25. Schreuder TCMA, Verwer BJ, van Nieuwkerk CM, et al. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 2008;14:2474-86.